Manfred Windisch

After graduation from the University of Graz in 1985, Dr. Windisch spent several years as head of a neurobiology research group dedicated to brain metabolism and animal model development. For many years, he was involved in University and industry research programs on neurodegenerative disorders in the US, Europe, and Asia, thereby establishing a global network of research collaborations. In 1999, Dr. Windisch founded the CRO JSW-Lifesciences focusing on the creation and standardization of improved transgenic rodent models for neurodegenerative diseases. Besides performing around 80 preclinical studies annually, JSW-Lifesciences was involved in more than 25 clinical trials in AD, MCI, PD and ALS from phase 1 to phase 3. The clinical trial experience included complex study designs using state of the art imaging techniques and CSF biomarkers. Based on his profound experience from more than 30 years in R&D, Dr. Windisch founded “NeuroScios – Neuroscience Optimized Solutions” in 2013, focusing on consulting services for drug development programs including clinical trial designs for CNS disorders such as AD, PD and ALS.